Literature DB >> 4004391

The management of empyema thoracis by thoracoscopy and irrigation.

J A Hutter, D Harari, M V Braimbridge.   

Abstract

A technique of irrigation for the management of empyema is described. Initial thoracoscopy under general anesthesia enabled full debridement and division of loculi within the empyema cavity under direct vision. Irrigation with two tubes was instituted until three consecutive cultures of irrigation fluid became sterile; then the chest drains were removed. The results in 12 patients are presented. Using this method, irrigation was required for an average of 14 days and chest drains were removed after an average of 20 days. Patients remained in the hospital for an average of 4.8 weeks. Tuberculous empyema was not found to be a contraindication to the irrigation technique.

Entities:  

Mesh:

Year:  1985        PMID: 4004391     DOI: 10.1016/s0003-4975(10)61988-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Videothoracoscopy in the treatment of early empyema: an initial experience.

Authors:  P Hornick; E R Townsend; D Clark; S W Fountain
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

Review 2.  Community for thoracoscopic surgery.

Authors:  Eunjue Yi; Sanghoon Jheon
Journal:  J Vis Surg       Date:  2017-03-31

3.  Empyema thoracis in AIDS.

Authors:  P Hornick; P L Smith
Journal:  J R Soc Med       Date:  1994-09       Impact factor: 5.344

4.  Intrapleural fibrinolytic treatment of multiloculated pediatric empyemas.

Authors:  Refik Ulkü; Abdurrahman Onen; Serdar Onat; Nihal Kilinç; Cemal Ozçelik
Journal:  Pediatr Surg Int       Date:  2004-06-08       Impact factor: 1.827

Review 5.  Management of empyema thoracis.

Authors:  J A Odell
Journal:  J R Soc Med       Date:  1994-08       Impact factor: 18.000

6.  Video-assisted thoracoscopic surgery in the management of pediatric empyema.

Authors:  R R Gandhi; G Stringel
Journal:  JSLS       Date:  1997 Jul-Sep       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.